Showing results (151-160 of 1,297) with videos related to

Sort By:
Pageof 130
Nephrology (Carlton, Vic.)|January 11, 2016
A review of linked health data in Australian nephrologySradha Kotwal, Angela C Webster, Alan Cass, et al.
BMC Health Services Research|December 29, 2017
A systematic review of adherence in Indigenous Australians: an opportunity to improve chronic condition managementJessica Langloh de Dassel, Anna P Ralph, Alan Cass
Australian and New Zealand Journal of Public Health|February 1, 2021
Using Pharmaceutical Benefit Scheme data to understand the use of smoking cessation medicines by Aboriginal and Torres Strait Islander smokersSamuel Keitaanpaa, Alan Cass, Marita Hefler, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2003
Late referral to a nephrologist reduces access to renal transplantationAlan Cass, Joan Cunningham, Paul Snelling, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2020
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational TrialAdeera Levin, Vlado Perkovic, David C Wheeler, et al.
The Cochrane Database of Systematic Reviews|June 1, 2014
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisSuetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, et al.
Archives of Internal Medicine|December 17, 2009
Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysisRachel Huxley, Crystal Man Ying Lee, Federica Barzi, et al.
Diabetes Care|August 24, 2017
Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?Nikolaus Marx, Darren K McGuire, Vlado Perkovic, et al.
The Cochrane Database of Systematic Reviews|April 17, 2009
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisSankar D Navaneethan, Francesca Pansini, Vlado Perkovic, et al.
Ethnicity & Disease|August 1, 2002
End-stage renal disease in indigenous Australians: a disease of disadvantageAlan Cass, Joan Cunningham, Paul Snelling, et al.
Pageof 130